ZEKE CAPITAL ADVISORS, LLC – Novo Nordisk A/S Transaction History
ZEKE CAPITAL ADVISORS, LLC portfolio value:
$1.66M
portfolio value
ZEKE CAPITAL ADVISORS, LLC quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -197K | $99.63 | 16.69K | |
| Q2 2022 | share | Increase | +13.34% | 1.96K shares | 224K | $111.43 | 16.69K |
| Q1 2022 | share | Increase | +9.01% | 1.21K shares | 122K | $111.05 | 14.73K |
| Q4 2021 | share | Increase | +5.75% | 735 shares | 287K | $111.45 | 13.51K |
| Q3 2021 | share | 0.00% | 0 shares | 157K | $96.01 | 12.77K | |
| Q2 2021 | share | Increase | +8.00% | 947 shares | 272K | $83.32 | 12.77K |
| Q1 2021 | share | Decrease | -5.06% | -630 shares | -72K | $67.06 | 11.83K |
| Q4 2020 | share | Increase | +26.13% | 2.58K shares | 184K | $68.52 | 12.46K |
| Q3 2020 | share | Increase | +0.23% | 23 shares | 41K | $68.1 | 9.88K |
| Q2 2020 | share | Decrease | -64.20% | -17.67K shares | -1.01M | $63.73 | 9.85K |
| Q1 2020 | share | Decrease | -25.43% | -9.39K shares | -480K | $58.59 | 27.53K |
| Q4 2019 | share | Decrease | -0.16% | -58 shares | 225K | $55.56 | 36.92K |
| Q3 2019 | share | Increase | +1.56% | 567 shares | 53K | $49.63 | 36.98K |
| Q2 2019 | share | Increase | +3.78% | 1.32K shares | 24K | $48.57 | 36.41K |
| Q1 2019 | share | Increase | +9.88% | 3.15K shares | 364K | $49.78 | 35.08K |
| Q4 2018 | share | Decrease | -75.20% | -96.82K shares | -4.59M | $43.17 | 31.93K |
| Q3 2018 | share | Increase | +2.79% | 3.49K shares | 293K | $44.17 | 128.75K |
| Q2 2018 | share | Increase | 0.00% | 125.26K shares | 5.77M | $43.22 | 125.26K |